Evaluating the impact of Marie Stopes International's digital family planning counselling application on the uptake of long-acting and permanent methods of contraception in Vietnam and Ethiopia: a study protocol for a multi-country cluster randomised controlled trial by Bates, LA et al.
STUDY PROTOCOL Open Access
Evaluating the impact of Marie Stopes
International’s digital family planning
counselling application on the uptake of
long-acting and permanent methods of
contraception in Vietnam and Ethiopia: a
study protocol for a multi-country cluster
randomised controlled trial
Laura A. Bates1†, Joseph P. Hicks1*† , John Walley1 and Emily Robinson2
Abstract
Background: Maintaining quality of care in family planning (FP) counselling in low-resource settings is challenging.
Job aids can help providers give more accurate and client-specific advice but require a provider to use them
effectively and consistently. Marie Stopes International (MSI) have designed the tablet-computer based Digital
Counselling Application (DCA), which prompts structured, supportive, client-specific and unbiased FP counselling. We
hypothesise that a systematic exploration of clients’ fertility intentions, medical eligibility and preferences will increase
their uptake of long acting and permanent methods of contraception (LAPMs).
Methods/design: We will conduct a two-armed, parallel, cluster randomised control trial across all MSI clinics (clusters)
in Ethiopia (24) and Vietnam (11), randomising 18 clinics to the intervention group and 17 to the control
group. Intervention providers will attend a two-day DCA-use training programme, and use DCA in their FP
counselling sessions. Usual care providers will counsel clients as before. We aim to recruit 75 clients who
have had FP counselling per clinic (2625 total), following them up via two telephone interviews, initially
within 2 days and then at 4 months. The primary outcome is defined as the proportion of clients who report
choosing a LAPM following FP counselling and will include switchers (FP counselling clients who switch from
using any other FP method) and adopters (FP counselling clients who adopt any FP method having not
previously been using one). We will also collect secondary outcomes at the initial follow-up (including the
proportion of clients reporting being recommended a LAPM by a provider and a range of measures of client
experience and satisfaction) and at the 4-month follow-up (including a range of measures of continuation
rates for different FP method types). In the intervention arm, we will also conduct mixed-methods sampling
to assess how providers use DCA (using an observational survey of provider–client interactions), and understand users’
experiences of receiving and giving DCA-based FP counselling (through in-depth interviews).
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Discussion: This trial will provide novel information on the feasibility and acceptability of health worker delivered FP
counselling using DCA, with robust evidence on its effectiveness at increasing the uptake of LAPMs in low-resource
settings.
Trial registration: ISRCTN, ISRCTN11040557. Registered on 2 March 2017 (retrospectively registered).
Keywords: Family planning counselling, Contraception, mHealth, Fertility, Reproductive health, Long-acting and
permanent methods, Client Centred, Digital counselling
Background
Access to a choice of contraceptive methods is import-
ant throughout a woman’s reproductive life as her cir-
cumstances and preferences change over time [1]. A
greater methods mix, or range of available family plan-
ning (FP) services, to address an unmet need is pro-
moted by the World Health Organisation (WHO) [2, 3]
and the United Nations [4].
FP service providers inform clients about available
methods in different ways across the private and public
sectors, ranging from group information sessions intro-
ducing all methods, to individual screening of a client’s
needs and wants and supporting a client’s selection of
methods. Paper-based handheld job aids, such as flip-
charts, are often used as reference manuals by providers
and decision-making aids for clients [5]. Information
leaflets and posters, reproductive anatomy models and
displays of contraceptive methods also support pro-
vider–client consultations, and the WHO eligibility
wheel is also widely used in low-income countries to
support providers in giving guidance on medically ap-
propriate methods [6]. However, the application of these
job aids varies across the private and public sectors, as
well as between providers within the same organisation.
Maintaining quality of care in FP counselling services is
vital for maximising service utilisation. Quality FP coun-
selling requires that providers offer impartial advice on a
broad mix of methods, by sharing details on side effects
and effectiveness of methods [7, 8]. FP service providers
must also understand their clients’ fertility intentions and
address their concerns towards different methods [9]. Yet
providers’ counselling can be confounded by various tech-
nical competency biases influenced by factors such as
their training, cadre, time available to counsel sufficiently
and demeanour [7, 10, 11]. Achieving quality FP counsel-
ling can improve client satisfaction, improve clients’ use of
services, improve safe and effective use of contraceptive
methods [5] and influence the likelihood of discontinu-
ation or switching to another method [1].
Contraceptives are used by two-thirds of married or
women in-union around the world, and almost 90% of
contraceptive users use modern methods [4]. However,
in 2015 less than half the total demand for FP to stop or
limit childbearing was being met by modern methods,
particularly in areas where contraceptive use is low, such
as Africa, or where couples rely on traditional methods
[4]. Contraceptive preferences and the promotion of
methods varies by country [12]. In Africa, short-acting
methods are more common whereas long-acting or per-
manent methods of contraception (LAPMs) are more
common in Asia. These preferences are influenced by a
country’s political history, access to a method mix and,
in some cases, cultural preferences and provider bias
[13]. In Ethiopia, the contraceptive prevalence rate is
low (29%), and short-acting methods dominate the
contraceptive method mix [14]. There is a skewed pref-
erence for injectable contraceptives (74%), despite
community-level provision and a scaling up of
long-acting methods since 2009 [14, 15]. However, use
of implants is increasing, from 0.2 to 5% in 2014, and
they are now the second most selected method [14]. In
Vietnam, the contraceptive prevalence rate is much
higher (65%), yet abortion rates are also high [16]. The
two child per married couple policy of Vietnam in the
1960–1990s meant intrauterine devices (IUDs) and tubal
ligation were the only modern methods promoted. How-
ever, for many women, IUDs are not medically appropri-
ate [17] and this lack of contraceptive choice coupled
with the social stigma of buying condoms and lack of
knowledge of contraceptives has resulted in the highest
abortion rate in Asia.
Marie Stopes International (MSI) seeks to help women
choose a contraceptive method that suits their individual
lifestyles and medical needs. In the past, MSI provided
FP counselling training for providers that focused on the
delivery of information from providers to the clients.
More recently, MSI’s training has changed, placing
greater emphasis on meeting the clients’ contraceptive
needs and preferences. Currently, MSI providers use
flipcharts to support their FP counselling sessions. How-
ever, providers typically use the flipcharts intermittently
and there is substantial variation between providers’ con-
sideration of clients’ circumstances and the suitability of
methods recommend. This can result in providers offer-
ing unnecessary or an overwhelming number of options
to clients, or just offering a subset of suitable options.
Therefore, given the increasingly affordable access to
tablet computers, the Medical Development Team at
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MSI developed a tablet-computer based digital job aid,
known as the Digital Counselling Application (DCA). The
aim of DCA is to provide a tool that: (1) promotes inter-
action between providers and clients by forcing providers to
ask clients a structured and systematic series of questions
and (2) provides the client with a personalised list of recom-
mended methods, based on an algorithm that uses informa-
tion about the client’s situation, which the provider enters
into DCA, removing the need for the provider to do this in
their head (and thereby provide advice of varying quality of
specificity). Women’s unmet need for modern methods, in-
cluding LAPMs, is significantly associated with women’s
education and empowerment, the quality of client counsel-
ling, partner discussions and exposure to media [18, 19].
In recognition of these factors, the intervention aims
to support the uptake of modern methods through qual-
ity client-centred counselling. The intention is to stand-
ardise the quality of care in FP counselling to inform
clients and empower them to select their preferred
method. We hypothesise that DCA will offer a more
client-focused counselling process, increasing providers’
consideration of clients’ circumstances and needs, redu-
cing bias in provider recommendations, limiting discus-
sion of all possible FP methods but expanding
discussion on client-preferred methods (as ranked by
DCA) designed to suit clients’ needs and preferences.
This is anticipated to improve users’ counselling experi-
ence and increase clients’ readiness to consider and
accept a LAPM. Our primary objective is, therefore, to
evaluate the effects of DCA on LAPM uptake among cli-
ents attending FP counselling at MSI clinics in Ethiopia
and Vietnam. We will also explore any effect of the
DCA-led client-centred counselling on continuation
rates of LAPM uptake, since providers are actively
prompted to provide an upfront discussion of the side
effects in advance of LAPM uptake compared to trad-
itional counselling. The trial is also supported by a quali-
tative exploration of providers’ and clients’ experience of
DCA, to identify where and how DCA can be improved.
Methods/design
This protocol follows the Standard Protocol Items: Rec-
ommendations for Interventional Trials (SPIRIT) checklist
(Additional file 1). The SPIRIT recommended schematic
diagram detailing the schedule of enrolment, interventions
and assessments is provided as Fig. 1.
Design and study setting
We will use a parallel-group, two-arm, cluster rando-
mised controlled trial design to evaluate whether our
STUDY PERIOD
Cluster 
enrolment
Cluster 
allocation Post cluster-allocation
TIMEPOINT -t2 -t1
t0 (client 
receives FP
counselling)
t1 (initial 
follow-up 
[within 2 
days])
t2 (4 month 
follow-up)
Cluster eligibility 
screen X
Cluster informed 
consent X
Cluster allocation X
Participant 
eligibility screen X
Participant 
informed consent X X
INTERVENTIONS:
DCA training & use X
Usual care X
ASSESSMENTS:
Baseline data X
Primary outcome X
Secondary 
outcomes X X
Fig. 1 SPIRIT schedule. DCA Digital Counselling Application, FP family planning.
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intervention is superior to the existing treatment (con-
trol). We will conduct the study in MSI clinics (formally
known as static service delivery centres) across Ethiopia
and Vietnam. All clinics in Ethiopia and Vietnam are in
urban areas, and typically serve clients with higher in-
comes than is average for the country. In 2015, 11% of
Ethiopian clients and 1% of Vietnamese clients visiting
clinics lived below the poverty line of $1.25. Although
MSI charges clients for FP services, they have a policy of
offering a discount or waiver for clients who cannot pay.
Typically, the vast majority of clients self-refer after
hearing of the services offered by MSI through social
networks.
Clinics are staffed by formally trained clinicians (pro-
viders), who are employed and trained by MSI, and the
intervention will be delivered by MSI FP providers at the
clinic level, with the clinic being the unit of randomisa-
tion. A clustered design is necessary because it will not
be feasible for clinic providers to switch between deliver-
ing the intervention (which involves training) or control
treatment to clients. Moreover, this design avoids the
risk of contamination between different providers within
clinics. In addition to the trial, we will use a structured
observational survey to explore how providers are using
DCA and counselling clients in the intervention arm.
We will also conduct a qualitative study using in-depth
interviews with providers and clients to understand their
experiences of using and receiving DCA-led FP counsel-
ling, respectively, which will also help us understand if
and how it can be improved.
Participants, recruitment and consent
We will invite all MSI clinics in Ethiopia (24) and
Vietnam (11) to participate in the study, via the respect-
ive MSI in-country directors. All providers will be in-
vited to participate, and we will seek verbal informed
consent from providers for their participation, but only
those passing an assessment of their knowledge of the
intervention at the end of the intervention training will
be eligible to continue to participate.
Eligible participants will be women aged 18–49 years
old who present at MSI clinics and receive FP counsel-
ling. During the recruitment phase of the trial, we will
recruit participants across all participating clinics as they
present consecutively for FP counselling, until clinics
reach their target sample size. Clients attending MSI
clinics for FP counselling will initially be asked, either by
the receptionist or by the provider (if there is no recep-
tionist), if they can be contacted by a researcher via tele-
phone in the next 2 days who will ask them some
questions about their experience of the study. Those
who agree will then be telephoned in the next 2 days by
a researcher for an exit interview. The researcher will
then seek formal verbal informed consent from the
client to conduct the exit interview and provide outcome
data for the trial. They will also be asked if they can be
contacted again at 4 months for a follow-up interview.
Those clients who agree will then be contacted at 4
months after their FP counselling session by a re-
searcher, again via telephone. Again they will first seek
formal verbal informed consent for the interview before
collecting the 4-month follow-up data. At both the ini-
tial and 4-month telephone interviews, clients who agree
to be contacted but who do not answer their phone or
are otherwise busy will be contacted again twice more
over subsequent days, before being recorded as lost to
follow-up. For clients lost to follow-up, their anonymous
basic demographic data along with their choice of FP
method will be collected from their clinic’s routine re-
cords (see Section 2.13 on statistical analyses for details
of which patients will be included in the analyses). Cli-
ents will not receive remuneration for their time.
We will also conduct a structured observation survey
of provider–client interactions during FP counselling
sessions in intervention arm clinics. For this survey, pro-
viders will be asked to participate by a researcher, who
will seek their written informed consent. The survey will
then be carried out in each participating clinic over the
course of a day or two, with all clients attending the
clinics for FP counselling being asked to participate in
the survey by the researcher, who will again seek their
written informed consent. An overview of the different
quantitative and qualitative components in the trial and
their interlinkages is provided in Fig. 2.
Intervention
MSI developed the intervention as part of their initiative
to promote client-centred counselling on FP (particularly
the provision of contraception) across all 31 countries
where they operate. The intervention consists of two
components: DCA and an integrated training package.
DCA is a software application that runs on an elec-
tronic tablet and, led by the provider, guides the client
through a series of questions, supported by visual aids.
The device and training package were developed by the
Medical Development team at MSI and pilot tested in
MSI clinics in South Africa to encourage feedback on its
usability and content. DCA is intended for day-to-day
use by trained providers during FP counselling sessions.
By prompting a structured and systematic discussion
and exchange of relevant information between providers
and clients about the client’s preferences, it is hoped
DCA will lead to more supportive, interactive and un-
biased counselling sessions.
DCA prompts the user (the provider) to ask each cli-
ent a series of key questions, starting with whether they
are currently using a FP method. If yes, they are asked
whether they are satisfied, and if no whether they have a
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FP method in mind or are open to exploring other
methods. The clients’ answers to these questions then
send them down one of three pathways. Pathway 1 is
called the satisfied user check-in, and is intended for cli-
ents seeking to renew their FP method. Pathway 2 helps
the client to explore all methods, and is intended to be
used by contraceptive users who are not satisfied with
their current method or by clients who are not currently
using any method. Pathway 3 is designed to support cli-
ents with a method in mind but who are not currently
using contraception.
The application gathers basic information on the cli-
ent, their medical eligibility and their lifestyle, and at the
end of the process provides a list of recommended
methods based on the information provided, with those
best fitting the clients’ responses listed at the top. The
provider is then encouraged to discuss the pros and cons
of the top three ranked methods with the client to ex-
plore the clients’ preferences and to help them make a
decision about which contraceptive method best fits
their lifestyle and needs. DCA has been designed to base
its ranking of methods on clients’ fertility intentions and
Fig. 2 Study components flow diagram. DCA Digital Counselling Application, FP family planning, MSI Marie Stopes International
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how effective (with regard to failure rates) the method
is. The application also reflects the methods available at
each centre. The application is not designed to explicitly
promote the uptake of LAPM, but DCA’s intention is to
offer client-centred counselling responsive to clients’
needs, which we expect to lead to an increased uptake of
LAPM as more suitable and effective methods for many
women’s FP needs. This means DCA is designed to
prompt the provider to identify each client’s fertility in-
tentions, medical eligibility and individual preferences,
and inform each client of the possible side effects and
complications of methods deemed by DCA most suit-
able to them. Side effects and complications are com-
monly left undiscussed, and so we also seek to explore if
client-centred counselling and an upfront discussion of
the barriers to uptake have any effect on clients’ continu-
ation rates. Providers using DCA will discuss the most
suitable methods with the client (including misconcep-
tions, side effects and benefits) and thereby increase cli-
ents’ readiness and likelihood of accepting a suitable
LAPM option (which offers greater effectiveness).
The integrated training package will consist of a 2-day
programme delivered to FP providers in Ethiopia and
Vietnam by MSI UK and in-country programme staff.
The first day of the programme will consist of a 45-min
presentation and group discussion on client-centred
counselling (what it is, barriers to achieving it, how it
may be different to usual counselling and its potential
benefits), a 90-min introduction to DCA (including
using the tablet and the application), a 90-min detailed
review of the DCA content (exploring hypothetical client
journeys through the application) followed by a 75-min
session for hands-on practice with the application and
reflection. Day two of the programme will consist of a
further practice session with the application using two
role plays, followed by knowledge tests and practical as-
sessments. We will deliver the training package to all
clinic providers in the intervention arm as a group work-
shop in Vietnam and then Ethiopia. The same training
format and role plays will be used to promote
consistency in providers’ interpretation of the scenarios
and use of the application during those scenarios. The
output of the training will involve a true/false knowledge
test on contraceptive methods, and providers will be in-
cluded in the trial only if they pass all questions.
Following implementation of the intervention, UK-
based MSI project staff will remain in close contact with
in-country MSI project staff to promote adherence to
the intervention by providers in the intervention arm
and to monitor the conduct of the trial.
Control
In the control arm, clinics providers will continue to
offer the usual provider–client FP counselling service.
Typically, this means providers offer an overview of
most or all methods before asking the client to select
one. However, if providers in control arm clinics have
not received MSI’s existing standard training on
client-centred counselling within the last 18 months
then they will receive refresher FP training. Providers in
both the control and intervention arms will have access
to their existing job aids, such as posters, diagrams, flip-
charts, anatomy models and the WHO contraceptive
wheel. Only providers in the intervention arm clinics
will have access to and be given training on DCA and
the tablets used to run DCA.
Existing procedures
Aside from the intervention procedures, and the recruit-
ment, consent and data collection processes, clinics in
both arms will be allowed to operate as normal with no
other changes to their day-to-day practices.
Primary outcome
The primary outcome will be reported LAPM uptake.
This is defined as the proportion of switchers and
adopters who report choosing a LAPM following FP
counselling (rather than a short-acting method).
Switchers are clients using any FP method at the time of
counselling who then change to any other FP method
following counselling. Adopters are clients who are not
using any FP method at the time of counselling but who
decide to start using any FP method following counsel-
ling. LAPM methods include contraceptive implants,
IUDs, intrauterine systems and tubal ligation, with all
other FP methods considered short-acting methods. This
outcome will be calculated from data collected at the
initial telephone exit interview, and its accuracy is,
therefore, dependent on the accuracy of clients’ re-
sponses. This primary outcome (reported LAPM uptake)
is already used by MSI as a clinic performance indicator,
making it feasible to collect this information. It is also a
key indicator of FP practices supporting sustainable de-
velopment goals 3 and 5.
Secondary outcomes
The following secondary outcomes use data from initial
client exit telephone interviews:
 Proportion of clients recommended a LAPM by
their provider.
 How well clients felt providers listened to their
needs, measured on a four-point Likert scale: (1)
listened well, (2) listened quite well, (3) did not listen
well or (4) did not listen at all well.
 The degree to which clients felt the methods
recommended by providers were relevant to their
needs, measured on a four-point Likert scale: (1)
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very relevant, (2) a bit relevant, (3) not very rele-
vant or (4) not at all relevant.
 How well clients felt they understood the potential
side effects of their chosen method, measured on a
four-point Likert scale: (1) understand very well, (2)
understand quite well, (3) do not understand well or
(4) do not understand at all well.
 How clients felt about the amount of information
given to them during counselling sessions, measured
on a five-point Likert scale: (1) much too little, (2)
slightly too little, (3) about right, (4) slightly too
much or (5) much too much.
 How clients felt about the length of their counselling
sessions, measured on a five-point Likert scale: (1)
much too short, (2) slightly too short, (3) about
right, (4) slightly too long or (5) much too long.
 How clients rated their experience of receiving
counselling, measured on a five-point numeric scale
where 1 was “bad” and 5 was “good”.
The following secondary outcomes use data from
client 4-month telephone interviews:
 Proportion of adopters or switchers who chose a
LAPM following their FP counselling session and
reported still using the same method at 4 months.
 Proportion of adopters or switchers who chose a
LAPM following their FP counselling session and
who report that they plan to continue using their
current method.
 Proportion of clients who chose any short-acting FP
method following their FP counselling and reported
still using the same method at 4 months.
 Proportion of clients who chose any short-acting FP
method following their FP counselling and who
report that they plan to continue using their current
method.
 How clients rated their overall satisfaction with the
FP method they chose following their FP counselling
at 4 months, measured on a five-point numeric scale
where 1 was “bad” and 5 was “good”.
Provider observation checklist outcomes
The outcomes for the provider observation checklist
consist primarily of closed-ended options to observed
actions relating to a range of desirable provider behav-
iours, including those relating to clearly and sensitively
explaining important information about the counselling
session and FP methods available, and interpersonal
skills and general conduct. The observation survey will
also record the number of methods recommended to cli-
ents, the method type chosen by clients and the length
of counselling sessions.
Sample size
Based on logistical considerations, we assume that we
can recruit 75 clients per clinic across 35 clinics during
the recruitment period. Based on routine MSI clinic
data, we estimate that the primary outcome of LAPM
uptake in switchers and adopters is currently typically
around 40%. We, therefore, estimate that we will have
80% power to detect an absolute increase in LAPM up-
take from 40% to 50.5% (judged by trial researchers and
MSI FP experts to be a sufficiently small, clinically im-
portant difference for these contexts) at a 5% level of
statistical significance, assuming a between-cluster coef-
ficient of variation of 0.2 (based on prior MSI routine
data), with 18 clinics in the intervention arm and 17 in
the control arm, and 75 clients recruited per clinic [20].
Provider observation survey sample size
We based the sample size for our provider observation
survey on being able to estimate all our proportional
outcomes with a precision (95% confidence intervals) no
wider than ±10 percentage points (i.e. assuming the least
precisely estimable proportion of 0.5), which for an as-
sumed design effect of 2 requires 193 observations. Lo-
gistically, we have resources to observe 14 providers,
and we, therefore, plan to conduct 196 observations,
split between eight providers in Ethiopia and six in
Vietnam (14 observations per provider).
Randomisation, allocation concealment and masking
For the main trial, all 35 clinics across Ethiopia and
Vietnam will be randomised by MSI (ER) simultaneously
via a computer program to either the intervention or
control arm in a restricted 18:17 (intervention : control)
ratio, following recruitment of providers in clinics and
after obtaining provider consent. It will, therefore, be
possible to conceal treatment arm allocation from pro-
viders and clients, but during the trial it will not be pos-
sible to blind (mask) either providers or clients to
treatment allocation, given the explicit nature of the
intervention components (e.g. following treatment allo-
cation, intervention providers will be trained, provided
with tablets and use DCA to counsel clients, and clients
will be taken through the DCA counselling process).
However, data collectors (telephone interviewers) will be
blinded to the allocation of clients. For the provider ob-
servation survey, we will subsequently select, via simple
random selection, eight providers in Ethiopia and six in
Vietnam, from all participating clinics.
Quantitative data collection and management
As MSI client data currently collected by clinics are not
available for research, we prepared data collection tools
to collect the required outcome data. There will be three
data collection processes, all conducted by researchers.
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First, to collect data on our quantitative primary and
secondary outcomes, as well as a range of relevant
socio-demographic covariate data, researchers will con-
duct initial client exit telephone interviews using a data
collection form. Second, researchers will also collect
additional client outcome data 4 months after their FP
counselling sessions on related secondary outcomes via
further telephone interviews using another data collec-
tion form. Third, researchers will record outcomes from
the structured provider observation survey via a struc-
tured observational checklist tool.
Data management will initially be the responsibility of
the in-country study leaders. For each data collection
process, an SPSS database will be created with consistent
coding and design, and this will be duplicated for use
across countries. The databases will then be collated and
merged by the study statistician, and checked for quality,
accuracy and completeness using standard data valid-
ation methods, such as range and logic checks. Errors,
anomalous values and missing values will then be ex-
plored along with in-country MSI staff against original
data forms, to clean and correct the databases where
possible before the database is locked. No personally
identifying data will be collected in any data collection
process, and so all stored client data will be anonymous.
Consent forms will, however, be linkable to client data in
the databases via a generic ID, and so will be stored in
secure locked cabinets. Given the nature of the interven-
tion and the very low risk of harms, it was decided not
to have a data monitoring committee for the trial.
Both MSI (ER) and the University of Leeds (JW, JPH
and LAB) will have full access to the final trial and asso-
ciated study datasets, although only the University of
Leeds will be involved in analysing the data.
Statistical analyses
We will use methods suitable for cluster trials with rela-
tively few clusters, analysing cluster-level summary mea-
sures (proportions) of all binary outcomes to account for
between-cluster variation, and reporting crude and
covariate-adjusted results [21]. We first will convert all
Likert and numeric scale outcomes into binary scale out-
comes. As laid out above, the four-point Likert scale
outcomes will be dichotomised by combining the first
two categories and then the final two categories. The
two 5-point Likert scale outcomes will be dichotomised
by combining the first two categories and then the final
three categories. The five-point numeric scale outcomes
will be dichotomised by combining the first three cat-
egories and then the final two categories. For all out-
comes, we will first estimate the crude intervention
effect as the difference between the mean intervention
arm and mean control arm cluster-level outcome pro-
portions (i.e. a risk difference), and we will estimate the
95% confidence intervals and p value associated with this
effect size estimate using an independent t-test.
We will then estimate covariate-adjusted results using
a two-stage method [21]. First, using a logistic regression
model, we will model the effects of our covariates of
interest on the individual-level binary outcomes, while
excluding the effect of treatment. We will then use the
individual-level model predicted values and the
individual-level observed values for each outcome to cal-
culate covariate-adjusted cluster-level difference resid-
uals. Lastly, we will use these values in place of
cluster-level summary outcome measures to estimate
covariate-adjusted risk differences, and again use t-tests
to estimate the associated 95% confidence intervals and
p values. We will adjust outcomes for covariates as
shown in Table 1. In addition, using the methods out-
lined in Hayes & Moulton [21] for analysing cluster-level
effect modification, we will assess whether the treatment
effect differs for the primary outcome between the fol-
lowing subgroups: Ethiopia vs Vietnam and switchers vs
adopters.
We will analyse client data based on the original allo-
cation of the clinic that they attended, but we will also
conduct sensitivity analyses where we will analyse client
data based on how the clinic they attended actually par-
ticipated in the study (i.e. as either an intervention or
control clinic). Prior to the analyses, we will assess the
level and pattern of any missingness in outcome or co-
variate data and investigate the likely causes of missing-
ness. We will conduct complete case analyses of
outcomes unless these investigations indicate there is
likely to be substantial bias introduced, in which case we
will use multilevel multiple imputation methods of ana-
lysis [22]. We will make our primary inferences about
the statistical significance of the results via formal hy-
pothesis testing. Statistical significance will be at the 5%
level based on the (two-sided) p values estimated for all
outcomes obtained from the covariate-adjusted analyses,
as these are likely to have more power and reduced bias
(when estimating the treatment effect) than the crude
analyses, which will help us to understand how any im-
balances in covariates between treatment arms influence
the treatment effect [23]. We will evaluate clinical sig-
nificance based on the effect size estimates and their
95% confidence intervals, with an increase of 10.5 per-
centage points or more in the primary outcome seen as
clinically significant. We will not adjust secondary out-
comes for multiple testing. No interim analyses are
planned. We will specify our planned analyses in a statis-
tical analysis plan prior to analysis, which will be pub-
lished with the results.
We will analyse the observation checklist outcomes
using survey methods appropriate for the clustered de-
sign of the study [24], via the survey [25] package in the
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statistical software R. We will primarily analyse survey
checklist outcomes descriptively, either as percentages
(categorical outcomes) or as means (continuous out-
comes), making inferences about the plausible range of
true values for outcomes based on their 95% confidence
intervals. We will calculate outcome results from the
pooled data and for each country separately, exploring
differences in outcomes between countries based on out-
come point estimates and 95% confidence intervals.
Qualitative data collection
In-depth interviews will be conducted with a subsample
of clients who received FP counselling with the applica-
tion, whose counselling session was observed and who
completed a first telephone interview and consented to
being contacted in the future. Purposive sampling will
seek to select individuals who received different
methods. Clients recruited to the telephone interview
will be called again by a researcher, who will seek verbal
consent to meet with them and record an in-depth inter-
view. Informed consent will be taken when the client
and researcher meet face to face, using a digital recorder
to record the client’s consent to be interviewed.
In-depth interviews will be conducted with a sub-
sample of providers who have been trained to use DCA
within the intervention arm, who were observed while
providing counselling and who are available to undertake
an in-depth interview. Purposive convenience sampling
will be used to recruit providers, to ensure that pro-
viders of all cadres are interviewed. The researcher will
seek verbal consent to meet with one provider per clinic
and record an in-depth interview. Informed consent will
be taken when the provider and researcher meet face to
face, using a digital recorder to record the provider’s
consent to be interviewed.
A topic guide will be prepared by LAB to structure the
interviews. These topic guides will be reviewed in ad-
vance by the research team, pre-tested prior to imple-
mentation and revised accordingly. With clients, we will
explore their experiences and attitudes to FP prior to the
counselling session, their experience of being counselled
with a provider led by DCA, their acceptance of the FP
options recommended by DCA, and their reflection on
any changed attitudes to LAPM. With providers, we will
explore their attitudes towards good and bad counselling
traits, their experience of and response to the training,
the acceptability and feasibility of DCA in practice, the
perceived impact of DCA on their FP counselling, and
discussions around how they use it.
In-depth interviews with clients will take place within
1 month of being counselled with DCA. In-depth inter-
views with providers will take place after they have used
DCA for 3 months. Research assistants fluent in the
local language and with qualitative data collection
Table 1 Planned covariate adjustment for covariate-adjusted analyses
Outcome Covariates adjusted
for
Primary (LAPM uptake among FP switchers and adopters) 1–8
Proportion of clients recommended a LAPM by their provider 1–8
How well clients felt providers listened to their needs 1–8
How relevant clients felt the method(s) recommended by providers were to their needs 1–8
How well clients felt they understood the potential side effects of their chosen method 1–3, 5–6, 8
How clients felt about the amount of information given to them during counselling sessions 1–8
How clients felt about the length of their counselling sessions 1–8
How clients rated their experience of receiving counselling 1–7
Proportion of adopters or switchers who chose a LAPM following their FP counselling session and reported still using the same
method at 4 months
1–9
Proportion of adopters or switchers who chose a LAPM following their FP counselling session and who report that they plan to
continue using their current method
1–9
Proportion of clients who chose any short-acting FP method following their FP counselling and reported still using the same
method at 4 months
1–9
Proportion of clients who chose any short-acting FP method following their FP counselling and who report that they plan to
continue using their current method
1–9
How clients rated their overall satisfaction with the FP method they received following their FP counselling at 4 months 1–8
FP family planning, LAPM long-acting or permanent method of contraception, MSI Marie Stopes International
Covariates: (1) country (Ethiopia or Vietnam), (2) client age, (3) client education level (none, primary, secondary, college or higher), (4) marital status (single or no
regular partner, regular partner, married, divorced or separated, refused to say), (5) FP intentions (trying to become pregnant now or within 1 year, aiming to
become pregnant within 2+ years, do not want any or anymore children or do not know), (6) current FP usage (currently use LAPM, currently use short-acting
or natural method or unsure what method, not currently using any FP method or have never used any FP method), (7) reason for visiting MSI clinic (seeking FP
health care, seeking abortion health care or seeking other health care), (8) overall initial rating of FP counselling experience (1–5, where 1 is “bad” and 5 is
“good”), (9) overall rating at 4 months of satisfaction with the method received (1–5, where 1 is “bad” and 5 is “good”)
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experience will be recruited to the study to collect all
telephone data. They will be given training on the study
rationale, obtaining consent, confidentiality, use of data
collection tools and data protection. These researchers
will be supervised by their lead in-country investigator.
Qualitative analysis and interpretation
Qualitative data will be audio-recorded and transcribed
by the in-country researchers. A sample of the original
transcripts will be checked by the in-country lead for
quality control. All identifying information will be re-
moved from the transcript prior to review and analysis
by LAB.
In-depth interviews with clients will be analysed by
thematic content analysis, using the analysis software
NVivo. The framework approach [26] will be applied to
help organise and compare the data. The framework ap-
proach is a systematic method that appreciates the itera-
tive nature of qualitative data analysis. Analysis will
follow four key stages: familiarisation, constructing a
thematic framework, indexing and mapping, and inter-
pretation. A thematic framework will be derived from
the research objectives and emergent themes, under
which the data will be organised, analysed and inter-
preted. We will aim to understand the acceptability to
providers and clients, and the feasibility (e.g. time taken
to counsel) of using DCA during FP counselling. We will
also identify a set of pragmatic recommendations to im-
prove DCA, training on DCA and the use of DCA in
practice, if such changes appear necessary.
Dissemination
Following completion of the study (after all 4-month
follow-up data have been collected), we will publish the
results of the trial in a peer-reviewed journal and present
them at relevant international conferences. We will also
report the results separately to the funder for their in-
ternal use.
Discussion
This trial will provide evidence on the effectiveness,
feasibility and acceptability of using a digital application
to structure FP consultations with clients and its associ-
ated impact on LAPM. Here we will identify the merit of
a digital application that aims to standardise and support
providers’ interactions with clients, yet remains flexible
enough to accommodate the life experiences and med-
ical suitability of clients visiting both quiet and busy cen-
tres. MSI Ethiopia and Vietnam recognise the need for
FP, which empowers women, men and young people to
achieve their sexual and reproductive health rights, and
reduces maternal mortality and morbidity. The trial will
inform how the use of DCA may impact their daily
counselling and method mix uptake.
This trial supports MSI’s commitment to provide ac-
cess to quality FP counselling to women, including
empowering women to choose a FP method that best
suits their needs. This goal spans across MSI’s 37 coun-
try programmes, where knowledge and acceptance of all
modern methods and provider-led counselling is highly
varied. The trial will, therefore, contribute to the cur-
rently very limited evidence on the roles that digital job
aids may play in improving the quality of counselling
provided across FP clinics (both MSI’s and other organi-
sations’ clinics). The findings of the study will be used by
MSI to assess the effectiveness of DCA in improving FP
outcomes and client experience. Depending on the re-
sults of the trial, the application will be considered for
use in other MSI country programme centres, and it
may be revised to incorporate the learning observed.
The outcomes (opportunities and challenges) of the
trial are also likely to be useful to governments and
non-governmental organisations considering using
digital job aids in FP counselling in similar health-care
settings.
Trial status
Recruitment to the trial started in Ethiopia and Vietnam
in January 2017, and was ongoing at the time of
submission.
Additional file
Additional file 1: SPIRIT checklist. Completed SPIRIT checklist for this
protocol. (DOC 120 kb)
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